Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Change in Inventory (2022 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Change in Inventory for 4 consecutive years, with $4.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Inventory rose 1.67% to $4.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.5 million, a 26.12% decrease, with the full-year FY2025 number at $7.5 million, down 26.12% from a year prior.
  • Change in Inventory was $4.9 million for Q4 2025 at Rhythm Pharmaceuticals, up from $2.5 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $4.9 million in Q4 2025 to a low of -$479000.0 in Q2 2025.
  • A 4-year average of $1.8 million and a median of $1.4 million in 2022 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: soared 31800.0% in 2023, then crashed 113.74% in 2025.
  • Rhythm Pharmaceuticals' Change in Inventory stood at $1.2 million in 2022, then dropped by 29.98% to $862000.0 in 2023, then soared by 462.18% to $4.8 million in 2024, then grew by 1.67% to $4.9 million in 2025.
  • Per Business Quant, the three most recent readings for RYTM's Change in Inventory are $4.9 million (Q4 2025), $2.5 million (Q3 2025), and -$479000.0 (Q2 2025).